Viewing Compound With Targets


Compound Report Overview

Compound Name: PROPARACAINE
Compound Identifier: 700709
Mol Structure 2D: 700709
Molecular Weight: 294
Formula: C16 H26 N2 O3
Development Status: US FDA Approved
SMILES: CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC
Compound Targets
Compound Gene Gene Type View
PROPARACAINE 168887 amiloride-sensitive cation channel 5, intestinal View
PROPARACAINE 135381 sodium channel, voltage-gated, type VII, alpha View
PROPARACAINE 135191 sodium channel, voltage-gated, type I, beta View
PROPARACAINE 137182 sodium channel, voltage-gated, type IV, alpha polypeptide View
PROPARACAINE 132900 sodium channel, voltage-gated, type XI, alpha View
PROPARACAINE 153849 sodium channel, nonvoltage-gated 1 alpha View
PROPARACAINE 153848 sodium channel, nonvoltage-gated 1 beta View
PROPARACAINE 165452 sodium channel, voltage-gated, type II, beta View
PROPARACAINE 150734 sodium channel, voltage-gated, type V, alpha polypeptide View
PROPARACAINE 165421 sodium channel, voltage-gated, type IX, alpha View
PROPARACAINE 165479 sodium channel, voltage-gated, type 2, alpha 1 polypeptide View
PROPARACAINE 165775 sodium channel, voltage-gated, type VIII, alpha polypeptide View
PROPARACAINE 127667 sodium channel, voltage-gated, type 10, alpha polypeptide View
PROPARACAINE 127751 sodium channel, nonvoltage-gated 1 gamma View
PROPARACAINE 133117 sodium channel, voltage-gated, type I, alpha View